248 related articles for article (PubMed ID: 19407012)
41. Engineering of sialylated mucin-type O-glycosylation in plants.
Castilho A; Neumann L; Daskalova S; Mason HS; Steinkellner H; Altmann F; Strasser R
J Biol Chem; 2012 Oct; 287(43):36518-26. PubMed ID: 22948156
[TBL] [Abstract][Full Text] [Related]
42. Altered O-linked glycosylation in benign and malignant meningiomas.
Talabnin C; Trasaktaweesakul T; Jaturutthaweechot P; Asavaritikrai P; Kongnawakun D; Silsirivanit A; Araki N; Talabnin K
PeerJ; 2024; 12():e16785. PubMed ID: 38274327
[TBL] [Abstract][Full Text] [Related]
43. Ocular mucins in dry eye disease.
Portal C; Gouyer V; Gottrand F; Desseyn JL
Exp Eye Res; 2019 Sep; 186():107724. PubMed ID: 31325452
[TBL] [Abstract][Full Text] [Related]
44. Competition between core-2 GlcNAc-transferase and ST6GalNAc-transferase regulates the synthesis of the leukocyte selectin ligand on human P-selectin glycoprotein ligand-1.
Lo CY; Antonopoulos A; Gupta R; Qu J; Dell A; Haslam SM; Neelamegham S
J Biol Chem; 2013 May; 288(20):13974-13987. PubMed ID: 23548905
[TBL] [Abstract][Full Text] [Related]
45. Benzyl-N-acetyl-alpha-D-galactosaminide inhibits the sialylation and the secretion of mucins by a mucin secreting HT-29 cell subpopulation.
Delannoy P; Kim I; Emery N; De Bolos C; Verbert A; Degand P; Huet G
Glycoconj J; 1996 Oct; 13(5):717-26. PubMed ID: 8909998
[TBL] [Abstract][Full Text] [Related]
46. Liver membrane proteome glycosylation changes in mice bearing an extra-hepatic tumor.
Lee A; Chick JM; Kolarich D; Haynes PA; Robertson GR; Tsoli M; Jankova L; Clarke SJ; Packer NH; Baker MS
Mol Cell Proteomics; 2011 Sep; 10(9):M900538MCP200. PubMed ID: 20167946
[TBL] [Abstract][Full Text] [Related]
47. The relative activities of the C2GnT1 and ST3Gal-I glycosyltransferases determine O-glycan structure and expression of a tumor-associated epitope on MUC1.
Dalziel M; Whitehouse C; McFarlane I; Brockhausen I; Gschmeissner S; Schwientek T; Clausen H; Burchell JM; Taylor-Papadimitriou J
J Biol Chem; 2001 Apr; 276(14):11007-15. PubMed ID: 11118434
[TBL] [Abstract][Full Text] [Related]
48. Efficient chemoenzymatic synthesis of O-linked sialyl oligosaccharides.
Blixt O; Allin K; Pereira L; Datta A; Paulson JC
J Am Chem Soc; 2002 May; 124(20):5739-46. PubMed ID: 12010048
[TBL] [Abstract][Full Text] [Related]
49. sPLA
Wei Y; Asbell PA
Exp Eye Res; 2020 Dec; 201():108209. PubMed ID: 33011237
[TBL] [Abstract][Full Text] [Related]
50. Characterization of terminal sialic acid linkages on human thymocytes. Correlation between lectin-binding phenotype and sialyltransferase expression.
Baum LG; Derbin K; Perillo NL; Wu T; Pang M; Uittenbogaart C
J Biol Chem; 1996 May; 271(18):10793-9. PubMed ID: 8631891
[TBL] [Abstract][Full Text] [Related]
51. Expression of CCR5 and its ligands CCL3, -4, and -5 in the tear film and ocular surface of patients with dry eye disease.
Choi W; Li Z; Oh HJ; Im SK; Lee SH; Park SH; You IC; Yoon KC
Curr Eye Res; 2012 Jan; 37(1):12-7. PubMed ID: 22029739
[TBL] [Abstract][Full Text] [Related]
52. Differential recognition of glycoprotein acceptors by terminal glycosyltransferases.
Yeh J; Cummings RD
Glycobiology; 1997 Mar; 7(2):241-51. PubMed ID: 9134431
[TBL] [Abstract][Full Text] [Related]
53. Quantitative assessment of successive carbohydrate additions to the clustered O-glycosylation sites of IgA1 by glycosyltransferases.
Stewart TJ; Takahashi K; Xu N; Prakash A; Brown R; Raska M; Renfrow MB; Novak J
Glycobiology; 2021 Jun; 31(5):540-556. PubMed ID: 33295603
[TBL] [Abstract][Full Text] [Related]
54. Alteration of galectin-3 in tears of patients with dry eye disease.
Uchino Y; Mauris J; Woodward AM; Dieckow J; Amparo F; Dana R; Mantelli F; Argüeso P
Am J Ophthalmol; 2015 Jun; 159(6):1027-1035.e3. PubMed ID: 25703476
[TBL] [Abstract][Full Text] [Related]
55. Suppression of core 1 Gal-transferase is associated with reduction of TF and reciprocal increase of Tn, sialyl-Tn and Core 3 glycans in human colon cancer cells.
Barrow H; Tam B; Duckworth CA; Rhodes JM; Yu LG
PLoS One; 2013; 8(3):e59792. PubMed ID: 23536887
[TBL] [Abstract][Full Text] [Related]
56. Differential Diagnosis of Sjögren Versus Non-Sjögren Dry Eye Through Tear Film Biomarkers.
Akpek EK; Wu HY; Karakus S; Zhang Q; Masli S
Cornea; 2020 Aug; 39(8):991-997. PubMed ID: 32195754
[TBL] [Abstract][Full Text] [Related]
57. Glycogene expression in conjunctiva of patients with dry eye: downregulation of Notch signaling.
Mantelli F; Schaffer L; Dana R; Head SR; Argüeso P
Invest Ophthalmol Vis Sci; 2009 Jun; 50(6):2666-72. PubMed ID: 19011014
[TBL] [Abstract][Full Text] [Related]
58. Metabolic glycoengineering through the mammalian GalNAc salvage pathway.
Pouilly S; Piller V; Piller F
FEBS J; 2012 Feb; 279(4):586-98. PubMed ID: 22151230
[TBL] [Abstract][Full Text] [Related]
59. Determination of the site-specific oligosaccharide distribution of the O-glycans attached to the porcine submaxillary mucin tandem repeat. Further evidence for the modulation of O-glycans side chain structures by peptide sequence.
Gerken TA; Gilmore M; Zhang J
J Biol Chem; 2002 Mar; 277(10):7736-51. PubMed ID: 11777921
[TBL] [Abstract][Full Text] [Related]
60. Mucins in contact lens wear and dry eye conditions.
Ramamoorthy P; Nichols JJ
Optom Vis Sci; 2008 Aug; 85(8):631-42. PubMed ID: 18677222
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
